Atidarsagen autotemcel OTL-200 (2) – Libmeldy®
Metachromatic leukodystrophy with a biallelic mutation in the ARSA gene
Characteristics
| Start date | 01.07.2026 |
|---|---|
| Resolution | 17.12.2026 – active procedure |
| INN | Atidarsagen autotemcel OTL-200 |
| Brand name | Libmeldy® |
| Pharm. company | Orchard Therapeutics GmbH |
| G-BA Procedure ID | D-1365 |
| Therapeutic area | Metabolic diseases Orphan |
| Reason for procedure | Reassessment: G-BA limitation |
Associated procedures
| Atidarsagen autotemcel OTL-200 (2) | Libmeldy® | Orchard Therapeutics GmbH | Metachromatic leukodystrophy with a biallelic mutation in the ARSA gene | n.d. | active procedure Orphan | |
| Atidarsagen autotemcel OTL-200 (1) | Libmeldy® | Orchard Therapeutics GmbH | Metachromatic leukodystrophy with biallelic mutation in the ARSA gene | 2–4 | 67% Hint for major additional benefit Orphan |
<< List of all resolutions